Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

PTCT
PTC Therapeutics, Inc.
stock NASDAQ

Market Open
Jul 30, 2026 2:52:29 PM EDT
75.40USD+1.222%(+0.91)511,034
64.65Bid   86.09Ask   21.44Spread
Pre-market
Jul 30, 2026 8:32:30 AM EDT
74.50USD+0.013%(+0.01)100
After-hours
Jul 27, 2026 4:00:30 PM EDT
75.80USD-0.026%(-0.02)0
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 25, 2022
02:13AM EST  PTC Therapeutics Inc. (PTCT) said on Tuesday that its supplemental New Drug Application seeking to expand the label of Evrysdi to include pre-symptomatic infants under 2 months old with spinal muscular atrophy has been accepted for priority review by the FDA.   RTTNews
01:00AM EST  FDA Grants Evrysdi(r) Priority Review Based on Results From Treating   PR Newswire
Jan 18, 2022
08:01AM EST  PTC Therapeutics Announces Launch of 8th Annual STRIVE(tm) Awards Program to   PR Newswire
Jan 13, 2022
04:30PM EST  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)   PR Newswire
08:01AM EST  PTC Therapeutics Announces Launch of 2022 Global Talent Pipeline Program   PR Newswire
Jan 10, 2022
07:40AM EST  PTC Therapeutics 2021 Net Product Revenue Up 29% - Quick Facts   RTTNews
07:15AM EST  PTC Therapeutics Reports $536 Mln 2021 Total Revenue Represents 41% Year-over-year Growth   RTTNews
07:01AM EST  PTC Therapeutics Provides an Update on Commercial Progress and R&D Pipeline at   PR Newswire
Jan 4, 2022
08:08AM EST  Waylivra Gets Innovative Drug Category Pricing To Treat Familial Chylomicronemia Syndrome In Brazil   RTTNews
08:03AM EST  Waylivra(tm) Receives Innovative Drug Category Pricing to Treat Familial   PR Newswire
Jan 3, 2022
08:01AM EST  PTC Therapeutics to Present at the 40th Annual J.P. Morgan Virtual Healthcare   PR Newswire
Dec 20, 2021
08:02AM EST  Oral Splicing Modifiers that Systemically Lower Huntington Disease Protein   PR Newswire
Dec 6, 2021
09:14AM EST  Evrysdi(r) Distinguished by Two Prestigious Awards for Outstanding Innovation   PR Newswire
Dec 2, 2021
04:31PM EST  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)   PR Newswire
Nov 16, 2021
08:01AM EST  PTC Therapeutics to Participate at Upcoming Virtual Investor Conference   PR Newswire
Oct 29, 2021
10:29AM EDT  Raymond James Maintains Outperform on PTC Therapeutics, Lowers Price Target to $55   Benzinga
09:38AM EDT  RBC Capital Maintains Sector Perform on PTC Therapeutics, Lowers Price Target to $42   Benzinga
08:52AM EDT  Credit Suisse Maintains Neutral on PTC Therapeutics, Lowers Price Target to $48   Benzinga
Oct 28, 2021
04:05PM EDT  PTC Therapeutics Sees FY21 Net Product Revenue $400M-$420M   Benzinga
04:03PM EDT  PTC Therapeutics Q3 EPS $(1.89) Misses $(1.40) Estimate, Sales $138.74M Beat $126.44M Estimate   Benzinga
04:01PM EDT  PTC Therapeutics Provides a Corporate Update and Reports Third Quarter 2021   PR Newswire
12:04PM EDT  PTC Therapeutics Earnings Perspective: Return On Capital Employed   Benzinga
08:26AM EDT  The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug   Benzinga
04:08AM EDT  Earnings Scheduled For October 28, 2021   Benzinga
Oct 26, 2021
08:01AM EDT  PTC Therapeutics to Participate at Upcoming Virtual Investor Conference   PR Newswire
Oct 25, 2021
08:04AM EDT  PTC Announces Expansion Of Translarna Label To Include Ambulatory Patients As Young As 2 Years Old In Brazil   Benzinga
08:01AM EDT  PTC Announces Expansion of Translarna(tm) Label to Include Ambulatory Patients   PR Newswire
Oct 24, 2021
11:45AM EDT  The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More   Benzinga
Oct 18, 2021
10:22AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2021   Benzinga
07:55AM EDT  B of A Securities Downgrades PTC Therapeutics to Underperform, Announces $38 Price Target   Benzinga
Oct 14, 2021
08:58AM EDT  PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2021   PR Newswire
08:33AM EDT  PTC Therapeutics Reports Opening Of Gene Therapy Manufacturing Facility In Hopewell, N.J.   RTTNews
08:31AM EDT  PTC Therapeutics Celebrates Opening of Gene Therapy Manufacturing Facility   PR Newswire
Oct 11, 2021
08:18AM EDT  PTC Therapeutics: Tegsedi Gets Category 1 Classification From CMED In Brazil   RTTNews
08:04AM EDT  PTC Therapeutics Announces Tegsedi Has Successfully Received Category 1 Classification From CMED (Drug Market Regulation Chamber) In Brazil   Benzinga
08:01AM EDT  Tegsedi(r) Receives Innovative Drug Category Pricing in Brazil   PR Newswire
Oct 7, 2021
08:24AM EDT  The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results   Benzinga
Oct 6, 2021
07:33AM EDT  The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal   Benzinga
Sep 29, 2021
04:31PM EDT  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)   PR Newswire
12:30PM EDT  PTC Therapeutics' Rare Genetic Disease Gene Therapy Shows Durable Improvement Even At 5 Years   Benzinga
08:26AM EDT  PTC Therapeutics Announces Results Show Long-Lasting And Holistic Improvements In Children With AADC Deficiency Treated With PTC-AADC Gene Therapy   Benzinga
08:19AM EDT  PTC Therapeutics Inc. (PTCT) presented a new analysis of five-year results that shows its gene therapy, PTC-AADC, leads to profound improvements in children with aromatic L-Amino acid decarboxylase or AADC deficiency. It is a previously intractable, fatal and devastating rare disorder of the central nervous system.   RTTNews
08:06AM EDT  PTC Therapeutics: Results Show Improvements In Children With AADC Deficiency Treated With PTC-AADC Gene Therapy   RTTNews
08:02AM EDT  Results Show Long-Lasting and Holistic Improvements in Children with AADC   PR Newswire
Sep 23, 2021
07:57AM EDT  The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data   Benzinga
Sep 21, 2021
08:20AM EDT  The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data   Benzinga
Sep 20, 2021
04:37PM EDT  PTC Therapeutics To Host Call To Discuss Results Of PTC518 Phase 1 Study For Huntington's Disease Program Thursday, Sept. 23, 2021 At 8 a.m. EDT   Benzinga
04:35PM EDT  PTC Therapeutics to Host Conference Call to Discuss Results of PTC518 Phase 1   PR Newswire
08:38AM EDT  PTC Therapeutics : Data Show Translarna Delays Loss Of Ambulation By Over 5yrs In Boys With NmDMD   RTTNews
08:35AM EDT  PTC Therapeutics, Inc. Highlights Presentation Of Data From STRIDE Patient Registry Showing Translarna Delays Loss Of Ambulation By More Than Five Years In Boys With Nonsense Mutation Duchenne Muscular Dystrophy   Benzinga
08:31AM EDT  STRIDE Data Show Translarna(tm) Delays Loss of Ambulation by More Than Five   PR Newswire
Sep 13, 2021
08:00AM EDT  Aadi Bioscience Appoints Emma Reeve to its Board of Directors   GlobeNewswire Inc
Sep 7, 2021
08:03AM EDT  PTC Therapeutics Recognizes 2021 STRIVE Awards Recipients for Initiatives   PR Newswire
Aug 27, 2021
08:01AM EDT  PTC Therapeutics to Participate at Upcoming Virtual Investor Conferences   PR Newswire
Aug 24, 2021
08:09AM EDT  The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal   Benzinga
07:06AM EDT  PTC Therapeutics' Waylivra Scores Approval In Brazil For Genetic Disorder   Benzinga
Aug 23, 2021
04:32PM EDT  PTC Therapeutics Announces Waylivra Approval In Brazil As First Treatment For Familial Chylomicronemia Syndrome   Benzinga
04:30PM EDT  PTC Therapeutics Announces Waylivra(tm) Approval in Brazil as First Treatment   PR Newswire
09:01AM EDT  Targeting the Putamen with Gene Therapy Leads to Sustained Improvements in   PR Newswire
Aug 20, 2021
04:31PM EDT  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)   PR Newswire
07:45AM EDT  The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data   Benzinga
Jul 30, 2021
12:28PM EDT  UPDATE: Credit Suisse On PTC Price Target Decrease Post-Earnings: Firm Notes Potential Dialogue For Biomarker-Driven Accelerated Approval Pathway For PTC518; Emphasizes Focus On DMD Franchise And Drivers Revolving Around Pipeline & PTC518   Benzinga
08:32AM EDT  Credit Suisse Maintains Neutral on PTC Therapeutics, Lowers Price Target to $50   Benzinga
Jul 29, 2021
04:44PM EDT  Recap: PTC Therapeutics Q2 Earnings   Benzinga
04:05PM EDT  PTC Therapeutics Sees FY21 Net Product Revenues $370M-$390M   Benzinga
04:01PM EDT  PTC Therapeutics Q2 EPS $(1.68) Beats $(1.82) Estimate, Sales $103.11M Miss $110.50M Estimate   Benzinga
04:01PM EDT  PTC Therapeutics Provides a Corporate Update and Reports Second Quarter 2021   PR Newswire
08:18AM EDT  The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs   Benzinga
04:23AM EDT  Earnings Scheduled For July 29, 2021   Benzinga
Jul 28, 2021
05:01PM EDT  PTC Therapeutics Reports Results From Part 2 Of FIREFISH Study Published In New England Journal Of Medicine   Benzinga
05:01PM EDT  Significant Improvements in Survival and Developmental Milestones Demonstrated   PR Newswire
10:46AM EDT  Earnings Outlook For PTC Therapeutics   Benzinga
Jul 25, 2021
10:05AM EDT  The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More   Benzinga
Jul 15, 2021
08:01AM EDT  PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2021   PR Newswire
Jun 24, 2021
08:02AM EDT  Results Add to Body of Evidence Confirming EMFLAZA(r)'s Benefit Over Prednisone   PR Newswire
Jun 23, 2021
08:17AM EDT  PTC Therapeutics, Inc. (PTCT) announced Wednesday that Evrysdi(risdiplam) was approved in Japan by the Japanese Ministry of Health, Labor and Welfare for the treatment of spinal muscular atrophy (SMA).   RTTNews
08:07AM EDT  PTC Therapeutics: Evrysdi Approved In Japan For Treatment Of Spinal Muscular Atrophy   RTTNews
08:01AM EDT  Evrysdi(tm) Approved in Japan for the Treatment of Spinal Muscular Atrophy   PR Newswire
Jun 15, 2021
04:31PM EDT  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)   PR Newswire
Jun 11, 2021
01:00AM EDT  Milestones as Healthy Children After Treatment with Evrysdi(tm) in RAINBOWFISH   PR Newswire
Jun 9, 2021
08:14AM EDT  PTC Therapeutics Elects Mary Smith To Board   RTTNews
08:02AM EDT  Health and Human Services Expert Mary L. Smith Joins PTC Therapeutics' Board of   PR Newswire
May 26, 2021
08:11AM EDT  PTC Therapeutics: FDA And EC Grant Orphan Drug Designation For PTC923 For Patients With Hyperphenylalaninemia   RTTNews
08:06AM EDT  PTC Therapeutics Reports Orphan Drug Designations Of PTC923 For Treatment Of Hyperphenylalaninemia   Benzinga
08:02AM EDT  PTC Therapeutics Announces Orphan Drug Designations of PTC923 for the Treatment   PR Newswire
May 19, 2021
08:01AM EDT  PTC Therapeutics to Participate at Upcoming Virtual Investor Conference   PR Newswire
May 17, 2021
09:38AM EDT  PTC Therapeuti : New Data Shows Devastating Impact Of AADC Deficiency On Caregivers   RTTNews
08:02AM EDT  New Data Shows Devastating Impact of AADC Deficiency on Caregivers   PR Newswire
May 14, 2021
07:59AM EDT  The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts   Benzinga
May 12, 2021
08:57AM EDT  The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron   Benzinga
May 5, 2021
07:43AM EDT  The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues   Benzinga
May 4, 2021
04:27PM EDT  PTC Therapeutics Q1 EPS $(1.83) Misses $(1.51) Estimate, Sales $117.94M Beat $98.80M Estimate   Benzinga
04:14PM EDT  PTC Therapeutics: Q1 Earnings Insights   Benzinga
04:02PM EDT  PTC Therapeutics Provides a Corporate Update and Reports First Quarter 2021   PR Newswire
08:10AM EDT  The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data   Benzinga
Apr 29, 2021
08:15AM EDT  The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx   Benzinga
Apr 27, 2021
08:03AM EDT  PTC Therapeutics to Participate at Upcoming Virtual Investor Conferences   PR Newswire
Apr 20, 2021
08:01AM EDT  PTC Therapeutics to Host Conference Call to Discuss First Quarter 2021   PR Newswire
Apr 19, 2021
04:31PM EDT  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)   PR Newswire
Apr 15, 2021
01:42AM EDT  Roche : Evrysdi Continues To Improve Motor Function And   RTTNews
01:00AM EDT  Continued Improvements in Motor Milestones in Infants with Type 1 Spinal   PR Newswire
Apr 14, 2021
08:05AM EDT  PTC Therapeutics Launches PTC Pinpoint Direct Program For Patient-Initiated Genetic Testing   Benzinga
08:01AM EDT  PTC Therapeutics Launches the PTC Pinpoint Direct(tm) Program for   PR Newswire
Apr 7, 2021
09:31AM EDT  PTC Therapeutics Received Gallup's "Don Clifton Strengths-Based Culture" Award   PR Newswire
08:52AM EDT  PTC Therapeutics Reports Will Host A Webinar To Discuss Its Huntington Disease Program Thurs., Apr. 15, 2021 At 9 a.m. EDT   Benzinga
08:51AM EDT  PTC Therapeutics to Host PTC518 Huntington Disease Deep Dive Webinar   PR Newswire
Apr 1, 2021
08:02AM EDT  PTC Therapeutics Announces $20M Payment Triggered By First Commercial Sale Of Evrysdi In EU Under License Agreement With Roche   Benzinga
08:02AM EDT  PTC Therapeutics Announces Commercial Milestone Payment Following the Recent   PR Newswire
Mar 30, 2021
08:06AM EDT  The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings   Benzinga
07:06AM EDT  PTC Therapeutics-Roche's Evrysdi Approved In Europe For Muscular Atrophy   Benzinga
01:27AM EDT  PTC Therapeutics Inc. (PTCT) said that the European Commission has approved Evrysdi or risdiplam for the treatment of spinal muscular atrophy in patients 2 months and older.   RTTNews
01:02AM EDT  PTC Therapeutics: European Commission Grants Marketing Authorization To Evrysdi For Spinal Muscular Atrophy   RTTNews
01:00AM EDT  PTC Therapeutics Announces the European Approval of Evrysdi(tm) for the   PR Newswire
Mar 29, 2021
10:04AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2021   Benzinga
07:27AM EDT  RBC Capital Upgrades PTC Therapeutics to Sector Perform, Announces $47 Price Target   Benzinga
Mar 16, 2021
03:03AM EDT  Genentech's, a member of the Roche Group (RHHBY), Evrysdi or risdiplam continues to demonstrate improvement or maintenance of motor function in people aged 2-25 with type 2 or type 3 spinal muscular atrophy, as per 2-year longer-term data from Part 2 of SUNFISH study.   RTTNews
02:00AM EDT  Results from the Second Year of Evrysdi(tm) (risdiplam) Treatment Demonstrated   PR Newswire
Mar 15, 2021
08:05AM EDT  PTC Highlights Presentation Of Results From Real-World Study Of DMD Patients Who Switched From Prednisone To EMFLAZA   Benzinga
08:01AM EDT  PTC Presents Results from a Real-World Study of Steroid Switching in the   PR Newswire
Mar 9, 2021
09:17AM EST  Spinal Muscular Atrophy Foundation And PTC Therapeutics Announce Collaboration To Advance Drug Discovery And Development Research In Regenerative Medicine; Financial Details Not Disclosed   Benzinga
08:11AM EST  SMA Foundation And PTC Expand Partnership To Advance Drug Discovery And Development Research In Regenerative Medicine   RTTNews
08:02AM EST  Partnership to Advance Drug Discovery and Development Research in Regenerative Medicine   PR Newswire
Mar 4, 2021
03:08PM EST  PTC Therapeutics Receives FDA Orphan Designation Status For Treatment Of Hyperphenylalaninemia   Benzinga
Feb 26, 2021
06:58AM EST  CHMP Adopts Positive Opinion For Evrysdi For Spinal Muscular Atrophy In Adults And Children Aged Two Months And Older   RTTNews
06:47AM EST  PTC Therapeutics Reports CHMP Positive Opinion For Evrysdi For Treatment Of Spinal Muscular Atrophy In Adults, Children Aged 2 Months, Older   Benzinga
06:41AM EST  CHMP Adopts Positive Opinion for Evrysdi(tm) for the Treatment of Spinal   PR Newswire
Feb 25, 2021
04:36PM EST  PTC Therapeutics Q4 EPS $(1.08) Misses $(0.94) Estimate, Sales $118.86M Beat $111.36M Estimate   Benzinga
04:02PM EST  PTC Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results   PR Newswire
08:08AM EST  The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants   Benzinga
04:03AM EST  Earnings Scheduled For February 25, 2021   Benzinga
Feb 24, 2021
05:16PM EST  Positive Data from FIREFISH Study of Evrysdi (risdiplam) in Infants with Type 1 Spinal Muscular Atrophy Published in The New England Journal of Medicine   Benzinga
05:08PM EST  Type 1 Spinal Muscular Atrophy Published in The New England Journal of Medicine   PR Newswire
Feb 17, 2021
08:29AM EST  PTC Therapeutics Initiates Second Stage Of FITE19 Phase 2/3 Clinical Trial Evaluating PTC299 For COVID-19   RTTNews
08:03AM EST  PTC Therapeutics Reports the Initiation of the Second Stage of the FITE19 Phase   PR Newswire
08:02AM EST  PTC Therapeutics Reports Initiation Of Second Stage Of FITE19 Phase 2/3 Trial Evaluating PTC299 For Treatment Of COVID-19   Benzinga
Feb 16, 2021
08:01AM EST  PTC Therapeutics to Participate at Upcoming Virtual Investor Conferences   PR Newswire
Feb 11, 2021
08:01AM EST  PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Year-End   PR Newswire
Feb 4, 2021
04:02PM EST  Translarna(tm) (ataluren) in Patients with Nonsense Mutation Duchenne Muscular Dystrophy   PR Newswire
Jan 14, 2021
08:03AM EST  PTC Therapeutics Opens Applications for the Annual STRIVE Awards Program and   PR Newswire
Jan 13, 2021
04:30PM EST  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)   PR Newswire
Jan 11, 2021
06:31AM EST  PTC Therapeutics Provides Update on R&D Pipeline and Commercial Progress at 39th Annual J.P. Morgan Healthcare Conference   Benzinga
06:31AM EST  PTC Therapeutics Provides Update on R&D Pipeline and Commercial Progress at   PR Newswire
Jan 8, 2021
07:25AM EST  The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs   Benzinga
Jan 5, 2021
10:11AM EST  Benzinga's Top Upgrades, Downgrades For January 5, 2021   Benzinga
09:56AM EST  Citigroup Upgrades PTC Therapeutics to Buy, Raises Price Target to $85   Benzinga
Jan 4, 2021
08:02AM EST  PTC Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference   PR Newswire
Dec 30, 2020
08:16AM EST  The Daily Biotech Pulse: Osmotica Faces Second FDA Rejection, UK Conditionally Approves AstraZeneca's Vaccine Candidate, Hepion NASH Data   Benzinga
Dec 29, 2020
05:42AM EST  PTC Therapeutics Issues U.S. Patent 10,874,672 'Methods for treating Huntington's disease'   Benzinga
Dec 23, 2020
08:31AM EST  The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut   Benzinga
Dec 18, 2020
04:30PM EST  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)   PR Newswire
Dec 16, 2020
07:12AM EST  Raymond James Maintains Outperform on PTC Therapeutics, Raises Price Target to $70   Benzinga
Dec 15, 2020
07:52AM EST  The Daily Biotech Pulse: Mesoblast Releases Mixed Data, MediWound Jumps On Distribution Deal, Kezar Life Sciences Rallies On Index Inclusion, Opiant Gets BARA Funding   Benzinga
Dec 9, 2020
08:02AM EST  PTC Therapeutics to Host Translarna(tm) Deep Dive Webinar   PR Newswire
Dec 8, 2020
08:04AM EST  The Daily Biotech Pulse: ASH Presentations, Axsome's Positive Midstage Readout, Follow-On Offerings   Benzinga
Dec 4, 2020
04:30PM EST  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)   PR Newswire
08:06AM EST  PTC Announces Translarna Approval In Russia For Treatment Of Duchenne Muscular Dystrophy   Benzinga
08:04AM EST  The Daily Biotech Pulse: BioCryst's Heredity Angioedema Treatment Clears FDA, Sutro Biopharma Readout, 2 IPOs   Benzinga
08:04AM EST  PTC Announces Translarna Approval In Russia For Treatment Of Duchenne Muscular Dystrophy   RTTNews
08:01AM EST  PTC Announces Translarna(tm) Approval in Russia for the Treatment of Duchenne   PR Newswire
07:43AM EST  The Daily Biotech Pulse: BioCryst's Heredity Angioedema Treatment Clears FDA, Sutro Biopharma Readout, 2 IPOs   Benzinga
Nov 30, 2020
10:01AM EST  Benzinga's Top Upgrades, Downgrades For November 30, 2020   Benzinga
08:21AM EST  PTC Therapeutics Initiates Global Phase 3 Clinical Trial To Evaluate Vatiquinone In Friedreich Ataxia   RTTNews
08:04AM EST  PTC Therapeutics Announces Initiation Of Global Phase 3 Clinical Trial To Evaluate Vatiquinone In Friedrich Ataxia   Benzinga
08:01AM EST  PTC Therapeutics Announces Initiation of Global Phase 3 Clinical Trial to   PR Newswire
05:54AM EST  RBC Capital Downgrades PTC Therapeutics to Underperform, Announces $45 Price Target   Benzinga
Nov 25, 2020
06:33AM EST  CENTOGENE Expands Partnership With PTC Therapeutics To 'Generate New Insights for Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency'   Benzinga
Nov 24, 2020
08:13AM EST  The Daily Biotech Pulse: Alnylam's Oxluma Snags Early FDA Approval, DBV Chief Scientific Officer To Depart, Decision Day For Liquidia   Benzinga
Nov 19, 2020
08:17AM EST  The Daily Biotech Pulse: Aquestive's Positive FDA Meeting, Prevail Awarded Patent, Neuro-Oncology Conference Gets Underway   Benzinga
08:01AM EST  PTC Therapeutics to Present at the Evercore ISI 3rd Annual HealthCONx Conference   PR Newswire
Nov 18, 2020
08:02AM EST  PTC Therapeutics Announces Key Regulatory Designations For PTC596 To Advance Treatment Of Two Rare Oncology Indications   Benzinga
08:02AM EST  PTC Therapeutics Announces Key Regulatory Designations for PTC596 to Advance   PR Newswire
07:30AM EST  The Daily Biotech Pulse: Kazia Jumps On Data Readout, Clinical Hold On Cellectis' Blood Cancer Study Lifted   Benzinga
Nov 17, 2020
08:13AM EST  PTC Therapeutics Announces That PTC518 Has Entered Into Phase 1 Clinical Trial For Huntington's Disease Program   Benzinga
08:08AM EST  PTC Therapeutics Says PTC518 Enters Into Phase 1 Trial For Huntington's Disease Program   RTTNews
08:03AM EST  PTC Therapeutics Announces that PTC518 Has Entered into a Phase 1 Clinical   PR Newswire
Nov 16, 2020
08:07AM EST  PTC Therapeutics Highlights Presentation Of Rare Disease Data At Virtual ISPOR Europe 2020 Conference   Benzinga
08:01AM EST  PTC Therapeutics Highlights Data on High Disease Burden and Value of Treatment   PR Newswire
Nov 10, 2020
08:40AM EST  The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies   Benzinga
Nov 5, 2020
07:54AM EST  The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping   Benzinga
Oct 29, 2020
04:10PM EDT  PTC Therapeutics Q3 EPS $(1.03) Misses $(0.04) Estimate, Sales $118.40M Beat $111.88M Estimate   Benzinga
04:02PM EDT  PTC Therapeutics Reports Third Quarter 2020 Financial Results and Provides a   PR Newswire
07:30AM EDT  The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal   Benzinga
04:08AM EDT  Earnings Scheduled For October 29, 2020   Benzinga
Oct 28, 2020
04:31PM EDT  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)   PR Newswire
12:38PM EDT  Benzinga's Top Upgrades, Downgrades For October 28, 2020   Benzinga
08:52AM EDT  UBS Initiates Coverage On PTC Therapeutics with Neutral Rating, Announces Price Target of $55   Benzinga
08:01AM EDT  PTC Therapeutics to Participate at Upcoming Virtual Investor Conferences   PR Newswire
Oct 26, 2020
08:19AM EDT  PTC Therapeutics Begins Registration-Directed Clinical Trial To Evaluate Vatiquinone In Mitochondrial Epilepsy   RTTNews
08:14AM EDT  PTC Therapeutics Announces Initiation Of A Registration-Directed Clinical Trial To Evaluate Vatiquinone In Mitochondrial Epilepsy   Benzinga
08:01AM EDT  PTC Therapeutics Announces Initiation of a Registration-Directed Clinical Trial   PR Newswire
Oct 22, 2020
08:01AM EDT  PTC Therapeutics and AADC Family Network Announce First-Ever AADC Deficiency   PR Newswire
Oct 21, 2020
08:34AM EDT  PTC Therapeutics Reports Approval From Brazil's National Health Surveillance Agency For Treatment Of Spina Muscular Atrophy   Benzinga
08:33AM EDT  Evrysdi(tm) (risdiplam) Continues to Make Global Progress for the Treatment of   PR Newswire
Oct 15, 2020
08:01AM EDT  PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2020   PR Newswire
Oct 7, 2020
10:09AM EDT  Benzinga's Top Upgrades, Downgrades For October 7, 2020   Benzinga
Sep 28, 2020
01:00AM EDT  Two-Year Data of Evrysdi(tm) (risdiplam) in Infants with Spinal Muscular   PR Newswire
Sep 25, 2020
04:30PM EDT  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)   PR Newswire
Sep 24, 2020
08:01AM EDT  PTC Therapeutics to Present at the Jefferies Virtual Gene Therapy/Editing Summit   PR Newswire
Sep 9, 2020
08:01AM EDT  PTC Therapeutics Launches PTC PINPOINT - A Genetic Testing Program for   PR Newswire
Sep 8, 2020
08:01AM EDT  PTC Therapeutics' 2020 STRIVE Awards for Duchenne Muscular Dystrophy Recognize   PR Newswire
Sep 3, 2020
08:01AM EDT  PTC Therapeutics to Present at the Cantor Virtual Global Healthcare Conference   PR Newswire
Aug 26, 2020
08:04AM EDT  PTC Therapeutics Receives $20M Milestone Payment From Roche Under License And Collaboration Agreement   Benzinga
08:01AM EDT  PTC Therapeutics Announces First Commercial Milestone Payment Following U.S.   PR Newswire
Aug 25, 2020
09:35AM EDT  Benzinga's Top Upgrades, Downgrades For August 25, 2020   Benzinga
06:36AM EDT  Raymond James Initiates Coverage On PTC Therapeutics with Outperform Rating, Announces Price Target of $63   Benzinga
Aug 21, 2020
04:30PM EDT  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)   PR Newswire
Aug 17, 2020
08:11AM EDT  PTC : EU Accepts Marketing Authorization Application For Evrysdi For Treatment Of Spinal Muscular Atrophy   RTTNews
08:05AM EDT  PTC to Receive a $15M Milestone Payment from Roche Following the Acceptance of the European Marketing Authorization Application for Evrysdi for the Treatment of Spinal Muscular Atrophy   Benzinga
08:01AM EDT  Application for Evrysdi(tm) (risdiplam) for the Treatment of Spinal Muscular Atrophy   PR Newswire
Aug 10, 2020
09:29AM EDT  B of A Securities Maintains Buy on PTC Therapeutics, Lowers Price Target to $58   Benzinga
08:41AM EDT  Credit Suisse Maintains Neutral on PTC Therapeutics, Lowers Price Target to $52   Benzinga
01:38AM EDT  Roche's Evrysdi Approved By FDA For Treatment Of Spinal   RTTNews
Aug 7, 2020
01:56PM EDT  PTC Therapeutics Announces FDA Approval Of Evrysdi For The Treatment Of Spinal Muscular Atrophy In Adults And Children 2 Months And Older   Benzinga
01:55PM EDT  Treatment of Spinal Muscular Atrophy in Adults and Children 2 months and older   PR Newswire
Aug 6, 2020
08:01AM EDT  PTC Therapeutics' Mary Frances Harmon Named One of the Most Inspiring Leaders   PR Newswire
Aug 5, 2020
04:14PM EDT  PTC Therapeutics Q2 EPS $(2.78) May Not Compare To $(1.30) Estimate, Sales $75.24M Miss $82.78M Estimate   Benzinga
04:02PM EDT  PTC Therapeutics Reports Second Quarter 2020 Financial Results and Provides a   PR Newswire
04:21AM EDT  Earnings Scheduled For August 5, 2020   Benzinga
Jul 22, 2020
08:01AM EDT  PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2020   PR Newswire
Jul 21, 2020
10:37AM EDT  SunTrust Robinson Humphrey Maintains Buy on PTC Therapeutics, Raises Price Target to $86   Benzinga
09:04AM EDT  PTC Therapeutics to Host Deep Dive Webinar on Splicing Platform   PR Newswire
Jul 20, 2020
01:10PM EDT  Hearing PTC Therapeutics Downgraded From Outperform To Neutral At Credit Suisse   Benzinga
07:49AM EDT  PTC Therapeutics Announces Agreement To Monetize Portion Of Risdiplam Royalty Stream For $650M; Royalty Pharma Acquires Royalty Interest In Risdiplam From PTC   Benzinga
07:48AM EDT  PTC Therapeutics Announces Agreement To Monetize Portion Of Risdiplam Royalty Stream For $650M   Benzinga
07:45AM EDT  Royalty Pharma plc (Nasdaq: RPRX) announced today an agreement with PTC Therapeutics, Inc. (Nasdaq: PTCT) to acquire a portion of PTCs royalty interest in risdiplam for a one-time payment of $650 million.   GlobeNewswire Inc
07:38AM EDT  PTC Therapeutics Announces Agreement To Monetize Portion Of Risdiplam Royalty Stream For $650M   Benzinga
07:36AM EDT  PTC Therapeutics Announces Deal To Monetize Portion Of Risdiplam Royalty Stream For $650 Mln From Royalty Pharma   RTTNews
07:31AM EDT  PTC Therapeutics Announces Agreement to Monetize a Portion of the Risdiplam   PR Newswire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC